Tower Research Capital (TRC)’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.4K | Buy |
7,654
+2,876
| +60% | +$10.7K | ﹤0.01% | 3454 |
|
|
2025
Q1 | $15.4K | Sell |
4,778
-45,475
| -90% | -$147K | ﹤0.01% | 3221 |
|
|
2024
Q4 | $280K | Buy |
50,253
+37,102
| +282% | +$207K | 0.01% | 1466 |
|
|
2024
Q3 | $142K | Buy |
13,151
+3,583
| +37% | +$38.7K | ﹤0.01% | 1945 |
|
|
2024
Q2 | $201K | Buy |
9,568
+8,586
| +874% | +$180K | ﹤0.01% | 2074 |
|
|
2024
Q1 | $31.3K | Sell |
982
-8,643
| -90% | -$275K | ﹤0.01% | 2615 |
|
|
2023
Q4 | $195K | Buy |
9,625
+8,506
| +760% | +$172K | ﹤0.01% | 2115 |
|
|
2023
Q3 | $14.2K | Sell |
1,119
-1,913
| -63% | -$24.4K | ﹤0.01% | 3701 |
|
|
2023
Q2 | $54.8K | Sell |
3,032
-5,334
| -64% | -$96.4K | ﹤0.01% | 2494 |
|
|
2023
Q1 | $144K | Buy |
8,366
+4,638
| +124% | +$79.8K | ﹤0.01% | 1559 |
|
|
2022
Q4 | $83K | Sell |
3,728
-673
| -15% | -$15K | ﹤0.01% | 1980 |
|
|
2022
Q3 | $35K | Sell |
4,401
-2,502
| -36% | -$19.9K | ﹤0.01% | 3468 |
|
|
2022
Q2 | $48K | Buy |
6,903
+5,121
| +287% | +$35.6K | ﹤0.01% | 2922 |
|
|
2022
Q1 | $27K | Sell |
1,782
-1,927
| -52% | -$29.2K | ﹤0.01% | 3248 |
|
|
2021
Q4 | $81K | Buy |
3,709
+610
| +20% | +$13.3K | ﹤0.01% | 2372 |
|
|
2021
Q3 | $84K | Buy |
3,099
+2,129
| +219% | +$57.7K | ﹤0.01% | 2534 |
|
|
2021
Q2 | $23K | Buy |
970
+366
| +61% | +$8.68K | ﹤0.01% | 3753 |
|
|
2021
Q1 | $26K | Buy |
+604
| New | +$26K | ﹤0.01% | 3677 |
|